Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
150%(3 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed267%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Safety and Efficacy Study of the Treatment of Humerus Fractures

NCT02394080
terminatednot_applicable

A Safety and Efficacy Study of the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease

NCT02373904
completednot_applicable

Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus

NCT02338492

Clinical Trials (3)

Showing 3 of 3 trials
NCT02394080Not Applicable

Safety and Efficacy Study of the Treatment of Humerus Fractures

Completed
NCT02373904Not Applicable

A Safety and Efficacy Study of the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease

Terminated
NCT02338492Not Applicable

Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3